Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

OR2AT4 helps reduce aging and cell damage in human skin cells.

High-dose methotrexate can cause severe skin and nail issues.

Cyproterone acetate can cause rare shortness of breath in women.

Anabolic steroid misuse is a major health issue causing severe health problems and requires better awareness and monitoring.

N-acetylcysteine may help treat uterine and placental issues in PCOS.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

New minoxidil compounds with better water solubility were made, but their full effects and safety need more research.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Timely and aggressive treatment is crucial for improving outcomes in severe complications of adult-onset Still's disease.

Salicylate helps wounds heal without scarring in mice.

A special diet can fix hair problems in argininosuccinase deficiency.

Deferoxamine may help protect inner ear cells from damage caused by oxidative stress.

Researchers created a new, efficient way to make Dutasteride, a hair loss and prostate drug, with high purity using a benzoyl group.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with fewer side effects.

Proguanil can cause anemia and hair loss in kidney disease patients.

Vitamin C supplementation can resolve pulmonary arterial hypertension caused by vitamin C deficiency.

Increasing SSAT makes skin more prone to cancer.

Sinapic acid and glabridin together help hair growth in androgenetic alopecia.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

A new topical treatment for hair loss shows promise by targeting androgen receptors.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Porphyria cutanea tarda causes skin issues due to an enzyme deficiency.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Surgical grafting may fix nail issues caused by valproic acid.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Selenium deficiency caused symptoms in a child, which improved with selenium supplements.

The combination therapy may be more effective for mild alopecia areata, especially in patients with allergies.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.